RITA WINN: Open Payments
NPI 1972000339 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 26 payments from 12 companies in 2025. Trend: 2023 $675 · 2024 $845 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 8 | $324 |
| Astellas Pharma US Inc | 1 | $107 |
| Eisai Inc. | 3 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $85 |
| ABBVIE INC. | 3 | $77 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Tempus AI, Inc | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $22 |
| pharmaand GmbH | 1 | $21 |
Products named: Tivdak, Veozah, Lenvima, ELAHERE, LYNPARZA, IMJUDO, JEMPERLI, XT CDX.
Industry payments across CO — which companies pay providers there.
